On the stock market since 2021, it operates in the world of consumer spending. It has 175 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
No real growth (-2% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
An investor who bought at the very peak is down 94% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $406.7M a year. A small number, but proof the product has real buyers.
A loss of $16.3M against $406.7M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 1.6 years. After that, the company needs to find new money.
On our five-subject report card, UHG sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: UHG is a high-risk stock — not yet profitable, and its future rides on its product catching on.